Kck. Lloyd et al., ACTIVATION OF SOMATOSTATIN RECEPTOR SUBTYPE-2 INHIBITS ACID-SECRETIONIN RATS, American journal of physiology: Gastrointestinal and liver physiology, 31(1), 1995, pp. 102-106
Somatostatin is a potent inhibitor of gastric acid secretion. Recently
, at least five distinct somatostatin receptor subtypes (SSTR) have be
en characterized and evaluated using relatively selective peptide anal
ogues of somatostatin. We sought to determine which somatostatin recep
tor subtypes are involved in peripheral regulation of gastric acid sec
retion. Fasted, male Sprague-Dawley rats were anesthetized and were im
planted with a double-lumen cannula in the stomach. Acid secretion was
measured in gastric samples collected every 10 min by backtitration t
o pH 7. After a 30-min basal period, a 2-h intravenous infusion of pen
tagastrin (24 mu g.kg(-1).h(-1) iv) was started. During the second pen
tagastrin hour, a l-h intravenous infusion of either vehicle (0.1% can
ine serum albumin in 0.9% saline) or somatostatin receptor agonists wa
s begun. The somatostatin receptor agonists included peptides with rel
ative specificity for SSTR(1-5) (somatostatin-14; 10 nmol.kg(-1).h(-1)
); SSTR(2), SSTR(3), and SSTR(5) [SMS-(201--995); 10 nmol kg(-1).h(-1)
]; SSTR(2) (1-1,000 nmol kg(-1).h(-1)); SSTR(3) (10-1,000 nmol.kg(-1).
h(-1)); and SSTR(5) (10-1,000 nmol.kg(-1).h(-1)). The SSTR(2) agonist
decreased pentagastrin-stimulated acid secretion dose dependently, fro
m 82 +/- 7% of maximum acid output at 1 nmol.kg(-1).h(-1) to 4 +/- 7%
of maximum at 100 nmol.kg(-1).h(-1). At 10 nmol.kg(-1).h(-1), the SSTR
(2) agonist inhibited acid secretion (40 +/- 7% of maximum) similarly
to somatostatin (37 +/- 4% of maximum) and SMS-(201--995) (31 +/- 4% o
f maximum). The SSTR(2) agonist inhibited acid secretion approximately
10- to 100-fold more potently than either the SSTR(3) or the SSTR(5)
agonist. These results indicate that somatostatin regulates gastric ac
id secretion by activation of SSTR(2) receptors.